|
Market Closed -
Nasdaq
16:00:00 2026-10-15 EDT
|
5-day change | 1st Jan Change | ||
| 20.60 USD | +3.00% |
|
-19.56% | +93.06% |
| 09-20 | Faeth Therapeutics, Inc.(NasdaqCM:FTH) added to S&P Biotechnology Select Industry Index | CI |
| 09-20 | Faeth Therapeutics, Inc.(NasdaqCM:FTH) added to S&P Global BMI Index | CI |
| Market Cap | 532M 475M 442M 402M 756M 50.42B 769M 5.3B 2.08B 26.31B 2B 1.96B 84.18B | P/E 2026 * |
-0.9x | P/E 2027 * | -6.25x |
|---|---|---|---|---|---|
| Enterprise Value | 532M 475M 442M 402M 756M 50.42B 769M 5.3B 2.08B 26.31B 2B 1.96B 84.18B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
95.05% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| FTH | Delayed | |
CBOE
| FTH | Real-time | |
|
Deutsche Boerse AG
| 4070 | Delayed |
| 1 day | +3.00% | ||
| 1 week | -19.56% | ||
| Current month | -30.73% | ||
| 1 month | -41.76% | ||
| 3 months | -34.54% | ||
| 6 months | -29.48% | ||
| Current year | +93.06% |
| 1 week | 19.85 |  | 26 |
| 1 month | 19.85 | | 36.61 |
| Current year | 8.37 | | 42.14 |
| 1 year | 7.45 | | 42.14 |
| 3 years | 5 | | 42.14 |
| 5 years | 5 | | 202 |
| 10 years | 5 | | 530 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anand Parikh
CEO | Chief Executive Officer | 40 | 2026-06-12 |
Brian Stephenson
DFI | Director of Finance/CFO | 45 | 2026-06-12 |
Deepak Tiwari
COO | Chief Operating Officer | - | 2026-08-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Bob Holmen
CHM | Chairman | 62 | 2024-12-31 |
Thomas Ricks
BRD | Director/Board Member | 72 | 2014-12-31 |
Kristian Humer
BRD | Director/Board Member | 51 | 2021-07-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/11/26 | Other | Director | 42,631 | 0.1654% | ||
| 9/11/26 | Free | Director | 25,000 | 0.0970% | ||
| 7/21/26 | Free | Chief Executive Officer | 398,018 | 1.5440% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.00% | -19.56% | +50.64% | +39.19% | 532M | |
| +0.21% | -4.63% | +55.34% | +71.32% | 68.98B | |
| +1.66% | +7.51% | +8.12% | +60.04% | 53.15B | |
| +3.14% | +7.17% | +12.48% | +44.42% | 50.83B | |
| +3.45% | +4.70% | +33.44% | +35.96% | 44.61B | |
| -2.20% | +0.61% | +281.88% | +532.76% | 40.57B | |
| +6.43% | +6.84% | +18.32% | +109.23% | 42.53B | |
| +1.28% | +1.39% | +11.69% | +45.10% | 30.95B | |
| +2.47% | -7.45% | +35.95% | +1.71% | 25.44B | |
| +1.74% | -2.02% | -13.55% | -12.92% | 22.66B | |
| Average | +2.12% | -0.55% | +49.43% | +92.68% | 38.03B | |
| Weighted average by Cap. | +1.96% | +2.30% | +51.51% | +103.61% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -233M -208M -193M -175M -330M -22.03B -336M -2.32B -907M -11.49B -873M -854M -36.77B | -104M -92.8M -86.25M -78.45M -148M -9.85B -150M -1.04B -405M -5.14B -390M -382M -16.44B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-15 | US$20.60 | +3.00% | 231,651 |
| 26-10-14 | US$20.00 | -7.02% | 421,406 |
| 26-10-13 | US$21.51 | -7.48% | 350,378 |
| 26-10-12 | US$23.25 | -10.68% | 309,830 |
| 26-10-09 | US$26.03 | +1.64% | 197,160 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FTH Stock
Select your edition
All financial news and data tailored to specific country editions
